Literature DB >> 1078839

Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.

H Shiku, P Kisielow, M A Bean, T Takahashi, E A Boyse, H F Oettgen, L J Old.   

Abstract

The cell-mediated cytotoxicity (CMC) of nonadherent cells from the peritoneal cavity (NAPC) of alloimmunized mice can be measured by the [3H]proline microassay. The exhibition of thymus-derived (T) cell antigens on these killer cells was studied by incubating them with the relevant T-cell antisera and complement (C), under optimal conditions for lysis, before performance of the CMC assay. Under these conditions, the following T-cell antigens were demonstrable on the killer population in terms of percent reduction in CMC by the respective antisera: (a) Thy-1.1 (83%) and Thy-1.2 (100%), (b) MSLA (86%), (c) NTA-RA (a T-cell antigen recognized by naturally occurring autoantibody of NZB mice) (62%), (d) Ly1.1 )58%, (e) Ly-2.1 (11%; considered a marginal result) and Ly-2.2 (63%), and (f) Ly-3.2 (77%). The following were not demonstrable: (g) TL, and (h) Ly-1.2. (i) The antigen Ly-3.1 was not studied. Omission of C deprived all T-cell antisera tested of their capacity to suppress CMC, indicating that the cell components recognized by such antisera may perform no direct function in CMC. On the assumption that all Ly+ cells are Thy-1+, it is clear that the T-cell members of the immune NAPC population must be heterogenous. This follows from the fact that the proportions of T cells lysed by different Ly antisera did not correspond with ensuing degree of loss of CMC capacity. The extremes were represented by anti-Ly-1.2 (74% Thy-1+ cells lysed, but no reduction in CMC) and Ly-3.2 (54% Thy-1+ cells lysed, with 77% reduction in CMC). From this initial survey it appears that the C57BL/6 mice killer T-cell population active in CMC in vitro is relatively rich in surface antigens of the Ly-2/Ly-3 category and relatively poor in representation of the Ly-1 surface antigens. It remains to be seen whether this killer cell phenotype, poor in Ly-1 and rich in Ly-2/Ly-3, is characteristic of the mouse generally. From these results it appears that subsets of T cells with different immunological functions may exhibit qualitative or quantitative differences in surface antigens specified by different Ly loci; this will be easier to assess in the future when the results of experiments with the same Ly antisera but dealing with T-cell functions other than CMC become available.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078839      PMCID: PMC2190510          DOI: 10.1084/jem.141.1.227

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.

Authors:  E A BOYSE; L J OLD; I CHOUROULINKOV
Journal:  Methods Med Res       Date:  1964

2.  Cell-mediated antitumor immune reactions under syngeneic conditions.

Authors:  J C Leclerc; A Senik; E Gomard; F Plata; J P Levy
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

Review 3.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

4.  Functional heterogeneity of murine lymphoid cells. 3. Differential responsiveness of T cells to phytohemagglutinin and concanavalin A as a probe for T cell subsets.

Authors:  J D Stobo; W E Paul
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

5.  Preparation of lymphocyte-specific antibody from anti-lymphocyte serum.

Authors:  N Shigeno; U Hämmerling; C Arpels; E A Boyse; L J Old
Journal:  Lancet       Date:  1968-08-10       Impact factor: 79.321

6.  Cytotoxic activity in vitro of thymus-derived lymphocytes sensitized to xenograft antigens.

Authors:  P C Beverley; E Simpson
Journal:  Nat New Biol       Date:  1972-05-03

7.  Sequences of synthesis of gamma-1 macroglobulin and gamma-2 globulin antibodies during primary and secondary responses to proteins, salmonella antigens, and phage.

Authors:  D C BAUER; M J MATHIES; A B STAVITSKY
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

8.  Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells.

Authors:  H Cantor; R Asofsky
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

9.  In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.

Authors:  E W Lamon; H M Skurzak; E Klein; H Wigzell
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

10.  THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES.

Authors:  A E REIF; J M ALLEN
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  72 in total

1.  Antigenic properties of lymph-node cells responding to allogeneic lymphocytes and to various concentrations of lectins.

Authors:  R Rabinowitz; R Laskov; M Schlesinger
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

2.  Surface markers on the T cells that regulate cytotoxic T-cell responses I. The Ly phenotype of suppressor T cells changes as a function of time, and is distinct from that of helper or cytotoxic T cells.

Authors:  A R Al-Adra; L M Pilarski; I F McKenzie
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

Review 3.  Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm.

Authors:  Ronald N Germain
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

4.  Cell surface antigens: invaluable landmarks reflecting the nature of cells.

Authors:  Toshitada Takahashi; Hiroshi Shiku
Journal:  Cancer Immun       Date:  2012-05-01

5.  Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice.

Authors:  G Fernandes; P Friend; E J Yunis; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

6.  Cell-mediated immunity to tumor antigen in Marek's disease: susceptibility of effector cells to antithymocyte serum and enhancement of cytotoxic activity by Vibrio cholerae neuraminidase.

Authors:  J M Sharma
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

7.  Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment.

Authors:  Amanda Waterstrat; Ying Liang; Carol F Swiderski; Brent J Shelton; Gary Van Zant
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

8.  T cells may express multiple activities: specific allohelp, cytolysis, and delayed-type hypersensitivity are expressed by a cloned T-cell line.

Authors:  G Dennert; S Weiss; J F Warner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  A new mouse cell-surface antigen (Ly-m18) defined by a monoclonal antibody.

Authors:  S Kimura; N Tada; Y Liu; U Hämmerling
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

10.  Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.

Authors:  C D Platsoucas; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.